Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 2 June 1989:
Vol. 244. no. 4908, pp. 1078 - 1081
DOI: 10.1126/science.2524877
Prev | Table of Contents | Next

Articles

Science, Vol 244, Issue 4908, 1078-1081
Copyright © 1989 by American Association for the Advancement of Science

articles

Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes

SL Hoffman, D Isenbarger, GW Long, M Sedegah, A Szarfman, L Waters, MR Hollingdale, PH van der Meide, DS Finbloom, and WR Ballou

Infectious Diseases Department, Naval Medical Research Institute, Bethesda, MD 20814.

The target of the CD8+ T cell-dependent immunity that protects mice immunized with irradiation-attenuated malaria sporozoites has not been established. Immune BALB/c mice were shown to develop malaria-specific, CD8+ T cell-dependent inflammatory infiltrates in their livers after challenge with Plasmodium berghei sporozoites. Spleen cells from immune BALB/c and C57BL/6 mice eliminated hepatocytes infected with the liver stage of P. berghei in vitro. The activity against infected hepatocytes is not inhibited by antibodies to interferon-gamma and is not present in culture supernatants. It is genetically restricted, an indication that malaria antigens on the hepatocyte surface are recognized by immune T effector cells. Subunit vaccine development will require identification of the antigens recognized by these T cells and a method of immunization that induces such immunity.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Acquired Immunity to Malaria.
D. L. Doolan, C. Dobano, and J. K. Baird (2009)
Clin. Microbiol. Rev. 22, 13-36
   Abstract »    Full Text »    PDF »
Effector CD8+ T Lymphocytes against Liver Stages of Plasmodium yoelii Do Not Require Gamma Interferon for Antiparasite Activity.
S. Chakravarty, G. C. Baldeviano, M. G. Overstreet, and F. Zavala (2008)
Infect. Immun. 76, 3628-3631
   Abstract »    Full Text »    PDF »
Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challenge.
C. L. Hutchings, A. J. Birkett, A. C. Moore, and A. V. S. Hill (2007)
Infect. Immun. 75, 5819-5826
   Abstract »    Full Text »    PDF »
A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge..
S. J. Dunachie, M. Walther, J. E. Epstein, S. Keating, T. Berthoud, L. Andrews, R. F. Andersen, P. Bejon, N. Goonetilleke, I. Poulton, et al. (2006)
Infect. Immun. 74, 5933-5942
   Abstract »    Full Text »    PDF »
Immunization with a Circumsporozoite Epitope Fused to Bordetella pertussis Adenylate Cyclase in Conjunction with Cytotoxic T-Lymphocyte-Associated Antigen 4 Blockade Confers Protection against Plasmodium berghei Liver-Stage Malaria.
S. Tartz, J. Kamanova, M. Simsova, P. Sebo, S. Bolte, V. Heussler, B. Fleischer, and T. Jacobs (2006)
Infect. Immun. 74, 2277-2285
   Abstract »    Full Text »    PDF »
Induction in Humans of CD8+ and CD4+ T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein.
R. Wang, J. Epstein, Y. Charoenvit, F. M. Baraceros, N. Rahardjo, T. Gay, J.-G. Banania, R. Chattopadhyay, P. de la Vega, T. L. Richie, et al. (2004)
J. Immunol. 172, 5561-5569
   Abstract »    Full Text »    PDF »
Successful Induction of CD8 T Cell-Dependent Protection Against Malaria by Sequential Immunization with DNA and Recombinant Poxvirus of Neonatal Mice Born to Immune Mothers.
M. Sedegah, M. Belmonte, J. E. Epstein, C.-A. Siegrist, W. R. Weiss, T. R. Jones, M. Lu, D. J. Carucci, and S. L. Hoffman (2003)
J. Immunol. 171, 3148-3153
   Abstract »    Full Text »    PDF »
Dendritic Cells Can Initiate Protective Immune Responses against Malaria.
O. Bruna-Romero and A. Rodriguez (2001)
Infect. Immun. 69, 5173-5176
   Abstract »    Full Text »    PDF »
The Complexity of Protective Immunity Against Liver-Stage Malaria.
D. L. Doolan and S. L. Hoffman (2000)
J. Immunol. 165, 1453-1462
   Abstract »    Full Text »    PDF »
Improving Protective Immunity Induced by DNA-Based Immunization: Priming with Antigen and GM-CSF-Encoding Plasmid DNA and Boosting with Antigen-Expressing Recombinant Poxvirus.
M. Sedegah, W. Weiss, J. B. Sacci Jr., Y. Charoenvit, R. Hedstrom, K. Gowda, V. F. Majam, J. Tine, S. Kumar, P. Hobart, et al. (2000)
J. Immunol. 164, 5905-5912
   Abstract »    Full Text »    PDF »
IL-12 and NK Cells Are Required for Antigen-Specific Adaptive Immunity Against Malaria Initiated by CD8+ T Cells in the Plasmodium yoelii Model.
D. L. Doolan and S. L. Hoffman (1999)
J. Immunol. 163, 884-892
   Abstract »    Full Text »    PDF »
Simultaneous Induction of Multiple Antigen-Specific Cytotoxic T Lymphocytes in Nonhuman Primates by Immunization with a Mixture of Four Plasmodium falciparum DNA Plasmids.
R. Wang, D. L. Doolan, Y. Charoenvit, R. C. Hedstrom, M. J. Gardner, P. Hobart, J. Tine, M. Sedegah, V. Fallarme, J. B. Sacci Jr., et al. (1998)
Infect. Immun. 66, 4193-4202
   Abstract »    Full Text »    PDF »
Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.
S Khusmith, Y Charoenvit, S Kumar, M Sedegah, R. Beaudoin, and S. Hoffman (1991)
Science 252, 715-718
   Abstract »    PDF »
Progress toward malaria preerythrocytic vaccines.
S. Hoffman, V Nussenzweig, J. Sadoff, and R. Nussenzweig (1991)
Science 252, 520-521
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)